top of page
ChatGPT Image Jun 2, 2026, 02_29_47 PM_e

UNLOCKING THE NEXT GENERATION OF ONCOLOGY THERAPIES VIA OUR DUAL THERAPEUTIC & DELIVERY PLATFORM

WE DELIVER WHAT'S BEEN IMPOSSIBLE, ORALLY 

​A next generation engineered exosome platform enabling targeted delivery of cancer therapies beyond the liver.

TODAY'S PROBLEM: BREAKTHROUGH THERAPIES. INADEQUATE DELIVERY.


ONCOXOME HAS THE SOLUTION COMBINING THE BEST IN CLASS THERAPIES WITH THE FIRST IN CLASS DELIVERY SYSTEM.

target (1).png

PRECISE ORAL DELIVERY

Targets cancer cells

beyond the liver

shield.png
minus.png

NO REPORTED TOXICITY

Patient friendly,

oral administration

TUMOR REDUCTION
& CONTROL

Dose escalation study

in vivo

enter.png

VERSATILE DELIVERY
SYSTEM

CRISPR Cas9, SiRNA,

mRNA, proteins

A SUPERIOR WAY TO DELIVER NOVEL CANCER THERAPIES

TRADITIONAL DELIVERY SYSTEMS

ChatGPT Image Jun 2, 2026, 02_59_17 PM.png

Poor targeting

ChatGPT Image Jun 2, 2026, 03_04_34 PM.png
ChatGPT Image Jun 2, 2026, 03_11_37 PM.png

Off-target

toxicity

Resistance development

ChatGPT Image Jun 2, 2026, 03_16_26 PM.png

Limited clinical impact

 VS 

ONCOXOME'S PLATFORM

ChatGPT Image Jun 2, 2026, 03_35_50 PM.png

Natural targeting

ChatGPT Image Jun 2, 2026, 03_40_33 PM.png

Precise delivery to tumor cells

ChatGPT Image Jun 2, 2026, 03_44_13 PM.png

Minimal toxicity / off-target effects

ChatGPT Image Jun 2, 2026, 04_02_11 PM.png

Potent efficacy potential

bottom of page